
Journal of Medicinal Chemistry p. 28 - 33 (1995)
Update date:2022-08-05
Topics:
Nozulak, Joachim
Kalkman, Hans O.
Floersheim, Philipp
Hoyer, Daniel
Schoeffter, Philipp
Buerki, Hans R.
The indolonaphthyridine 8 is described as a selective 5-HT2C/2B vs 5-HT2A receptor antagonist.The compound was synthesized in seven steps starting from indoline and isonicotinic acid chloride.The key step is a photocyclization of the indolinyl tetrahydropyridinocarbamic acid ethyl ester 4 to the cis-octahydroindolo<1,7-bc><2,6>naphthyridinecarbamic acid ethyl ester 5.The synthesis was accomplished by reduction with aluminum hydride and racemic resolution.The indolonaphthyridine 8 exerted the binding profile of a selective 5-HT2C receptor ligand (pKD 7.8) and behaved as an antagonist on the 5-HT-induced accumulation of inositol phosphates in pig choroid plexus cells (pKB 7.13).Compound 8 dose-dependently inhibited the ACTH response to MK-212 in rats and the MK-212-induced hypophagic effect with an ID50 value of 0.3 mg/kg sc.Compound 8 acted as a 5-HT2B receptor antagonist at the rat stomach fundus with a pKB value of 7.34.
View MoreShenzhen JYMed Technology Co.,Ltd.
website:http://www.jymedtech.com
Contact:+86-755-26612112
Address:1#8,9/F, Biomedicine innovation Industrial Park, No.14, Jinhui Road, Pingshan Sistrict, Shenzhen, China
website:http://www.konochem.com
Contact:86-29-86107037
Address:No.170 West Avenue,Xi’an 710082,China
Shanghai Send Pharmaceutical Technology Co., Ltd.
website:http://www.shsendpharma.com
Contact:021-58088081, +8613585868794
Address::Room A601, Building 1,NO. 800 Qingdai Road Pudong District Shanghai,China
jiangsu senxuan pharmaceutical and chemical co.,ltd
Contact:86-523-87982810
Address:hongqiao industrial zone,taixing,jiangsu china
Xinchang Jiu Xin Pharmaceutical Co., Ltd
website:http://www.jiuxinpharm.com
Contact:86 137 5756 8585
Address:Poyang industry Park
Doi:10.1016/j.tetlet.2012.10.028
(2012)Doi:10.3184/030823409X416974
(2009)Doi:10.1016/j.ica.2012.09.034
(2013)Doi:10.1021/om300994j
(2012)Doi:10.1007/s00044-012-0347-9
(2013)Doi:10.1021/co500020a
(2014)